Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.39)
# 956
Out of 5,127 analysts
95
Total ratings
38.71%
Success rate
7.75%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $12.74 | +135.48% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $319.54 | +275.54% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $3.97 | +277.83% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $20.51 | +255.92% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.72 | +1,353.49% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $488.26 | +84.33% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $33.26 | +125.50% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $7.53 | +856.18% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $8.86 | +306.32% | 5 | Oct 28, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $23.91 | +226.22% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $13.00 | +53.85% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $5.94 | +337.71% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.17 | +241.88% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.82 | +1,941.88% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $40.88 | +254.70% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $30.25 | +68.60% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.20 | +400.00% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $14.01 | +242.61% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $74.88 | +24.20% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $26.12 | +187.14% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $37.07 | +183.25% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $35.00 | +5.71% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $6.27 | +314.67% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.71 | +3,821.57% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $46.01 | +110.82% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $24.83 | +206.08% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.69 | +433.05% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $11.79 | +154.45% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $10.38 | +15.61% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.60 | +1,263.64% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.26 | +563.72% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.23 | +205.93% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $49.95 | +60.16% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $78.93 | +17.83% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $27.49 | +107.35% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.45 | +1,129.36% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.90 | +2,123.46% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $83.19 | -57.93% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.83 | +529.07% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.23 | +2,320.47% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $63.36 | +13.64% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $13.95 | +258.42% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.84 | +4,656.24% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.62 | +2,806.04% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.75 | +2,747.46% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $100.54 | -23.41% | 1 | Jul 31, 2020 |
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $12.74
Upside: +135.48%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $319.54
Upside: +275.54%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $3.97
Upside: +277.83%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $20.51
Upside: +255.92%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.72
Upside: +1,353.49%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $488.26
Upside: +84.33%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $33.26
Upside: +125.50%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $7.53
Upside: +856.18%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $8.86
Upside: +306.32%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $23.91
Upside: +226.22%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $13.00
Upside: +53.85%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $5.94
Upside: +337.71%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.17
Upside: +241.88%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.82
Upside: +1,941.88%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $40.88
Upside: +254.70%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $30.25
Upside: +68.60%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.20
Upside: +400.00%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $14.01
Upside: +242.61%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $74.88
Upside: +24.20%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $26.12
Upside: +187.14%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $37.07
Upside: +183.25%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $35.00
Upside: +5.71%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $6.27
Upside: +314.67%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.71
Upside: +3,821.57%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $46.01
Upside: +110.82%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $24.83
Upside: +206.08%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.69
Upside: +433.05%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $11.79
Upside: +154.45%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $10.38
Upside: +15.61%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.60
Upside: +1,263.64%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.26
Upside: +563.72%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.23
Upside: +205.93%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $49.95
Upside: +60.16%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $78.93
Upside: +17.83%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $27.49
Upside: +107.35%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.45
Upside: +1,129.36%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.90
Upside: +2,123.46%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $83.19
Upside: -57.93%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.83
Upside: +529.07%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.23
Upside: +2,320.47%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $63.36
Upside: +13.64%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $13.95
Upside: +258.42%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.84
Upside: +4,656.24%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.62
Upside: +2,806.04%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.75
Upside: +2,747.46%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $100.54
Upside: -23.41%